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Abstract
Mutations in the human genes PRESENILIN1 (PSEN1), PRESENILIN2 (PSEN2) and AMY-
LOID BETA A4 PRECURSOR PROTEIN (APP) have been identified in familial Alzheimer’s
disease (AD). The length of mitochondrion-endoplasmic reticulum (M-ER) appositions is
increased in Psen1-/-/Psen2-/- double knockout murine embryonic fibroblasts and in fibro-
blasts from AD-affected individuals. Development of an easily accessible, genetically
manipulable, in vivo system for studying M-ER appositions would be valuable so we
attempted to manipulate M-ER apposition length in zebrafish (Danio rerio) embryos. We
injected fertilized zebrafish eggs with antisense morpholino oligonucleotides (MOs) that
inhibit expression of zebrafish familial AD gene orthologues psen1 and psen2. Furthermore,
we treated zebrafish embryos with DAPT (a highly specific γ-secretase inhibitor) or with
sodium azide (to mimic partially hypoxic conditions). We then analyzed M-ER apposition in
an identified, presumably proliferative neural cell type using electron microscopy. Our analy-
sis showed no significant differences in M-ER apposition lengths at 48 hours post fertiliza-
tion (hpf) between psen1 & psen2 MO co-injected embryos, embryos treated with DAPT, or
sodium azide, and control embryos. Instead, the distribution of M-ER apposition lengths into
different length classes was close to identical. However, this indicates that it is feasible to
reproducibly measure M-ER size distributions in zebrafish embryos. While our observations
differ from those of murine and human studies, this may be due to differences in cellular dif-
ferentiation and metabolic state, cell age, or species-specific responses. In particular, by
focusing on a presumably proliferative embryonic cell type, we may have selected a cell
heavily already reliant on anaerobic glycolysis and less responsive to factors affecting M-ER
apposition. Future examination of more differentiated, more secretory cell types may reveal
measurable responses of M-ER apposition to environmental and genetic manipulation.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by the occurrence of
memory loss in its initial stages, with other effects such as the impairment of speech and motor
ability, depression, hallucinations, behaviour disturbances and, ultimately death in more
advanced stages of the disease [reviewed in [1]]. The major neuropathological hallmarks of the
disease in the brain are extracellular deposits of Amyloid beta (Aβ) peptide in “plaques”, and
intracellular neurofibrillary tangles, which are composed of hyperphosphorylated forms of the
tau protein. The exact mechanism of the disease remains unclear. There have been numerous
hypotheses suggested with the most widely accepted being the amyloid cascade hypothesis [2].
This posits that the accumulation of Aβ, either via overproduction or lack of clearance, leads to
its oligomerization and deposition in the brain and, ultimately, to neuronal dysfunction,
degeneration and death.
The majority of AD cases are sporadic (sAD), with a small number of cases that are familial
(fAD). Familial AD characteristically has an early age of onset (<65 years). Although only
accounting for a small percentage of AD cases, most of our understanding of the molecular
events underlying the development of AD comes from fAD, since genetic analysis can be used
to identify the genes and proteins involved.
Mutations in the PRESENILIN genes (PSEN1 and PSEN2) [3, 4] and the AMYLOID BETA
A4 PRECURSOR PROTEIN (APP) [5] gene have been identified in fAD. The PRESENILIN
proteins are the catalytic components of γ-secretase enzyme complexes which cleave type I
transmembrane proteins. APP, Notch, E-cadherin, Jagged and a great number of other pro-
teins are substrates of γ-secretase [6]. The cleavage of APP by γ-secretase forms the Aβ peptides
found in the amyloid plaques of AD brains [7]. It has been shown that AD associated PRESE-
NILIN mutations commonly cause partial or severe loss of function of γ-secretase [8]. Accord-
ingly, γ-secretase-specific inhibitors such as DAPT have been suggested as an attractive tool
for study of AD pathogenesis and several γ-secretase inhibitors have entered trials to inhibit
Aβ production as a potential AD therapy [reviewed in [9]. (This approach was recently criti-
cized by Kelleher and Shen who suggested instead that drugs be found to restore the lost γ-
secretase activity [10].) The therapeutic failure of γ-secretase inhibitor trials has been ascribed,
in part, to unintended inhibition of cleavage of other γ-secretase substrates such as Notch [11,
12]. However, PRESENILIN proteins also possess functions independent of their role in γ-
secretase. For example, before endoproteolysis to activate its γ-secretase activity, the PRESENI-
LIN1 holoprotein plays a role in the acidification of lysosomes through facilitation of glycosyl-
ation of the V0a1 subunit of v-ATPase [13]. PRESENILINs also regulate β-catenin stability via
an Axin-independent pathway for phosphorylation of β-catenin [14] and form Ca2+ leak chan-
nels in the endoplasmic reticulum that allow the release of Ca2+ to the cytoplasm [15].
The subcellular localizations of the components of γ-secretase and its substrate APP have
been of great interest since their elucidation would provide further insight into the pathogene-
sis of AD. Various studies have found PRESENILINs located in almost all membranous com-
partments of the cell [16–22]. A recent discovery by Area-Gomez and colleagues identified a
previously unrecognized compartment of PSEN1 and PSEN2 enrichment. When examining
mammalian cell membrane fractions they found the PRESENILINs to be located predomi-
nantly in the endoplasmic reticulum (ER) and specifically in a sub-compartment of the ER
known as the mitochondria-associated ER membrane (MAM) [23]. The MAM is a lipid raft-
like compartment [24] that contains various enzymes involved in critical cellular functions
including the synthesis and transfer of phospholipids [25], oxidative protein folding [reviewed
in [26]], cholesterol metabolism [27] and calcium homeostasis [28]. Interestingly, MAM is also
the site of formation of autophagosomes [29] and is involved in the UPR [30]. The MAM is
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physically linked to the outer mitochondrial membrane by protein tethers that are sufficiently
stable for MAM to be co-isolated with mitochondria by subcellular fractionation (reviewed in
[31]). Further work by Area-Gomez et al. [32] looked at the degree of M-ER apposition in dou-
ble knockout murine embryonic fibroblasts (MEFs) and AD patient cells by electron micros-
copy. Interestingly, they observed that the lengths of M-ER appositions are increased in
Psen1-/-/Psen2-/- double knockout MEFs and well as in fibroblasts from both fAD and sAD
individuals compared to control fibroblasts. Increased levels of phospholipid and cholesteryl
ester synthesis in MEFs and in fibroblasts from AD individuals were also seen along with the
increase in M-ER physical association. Additionally, it has been shown that activity of the
APOE ε4 isoform (the main genetic risk factor for sporadic AD) upregulates the physical
extent and phospholipid synthesis activity of MAM [33]. This suggests that increased M-ER
communication due to upstream events may be a common factor in fAD and sAD. Perturba-
tions to MAM function might possibly result in particular features of AD that the amyloid
hypothesis fails to explain.
The zebrafish, Danio rerio, is advantageous as a model organism for the study of human dis-
ease. Zebrafish embryos are robust and can undergo experimental manipulations such as the
injection of MOs into embryos to modify simultaneously the expression of multiple genes.
Embryos are produced in large numbers and develop rapidly [34]. Zebrafish possess genes
orthologous to human APP, PSEN1 and PSEN2 along with the other components of the γ-
secretase complex [35–37]. To date, the zebrafish animal model has not been used to study
M-ER apposition. Our previous work has revealed aspects of PRESENILIN protein function
not seen in cell culture systems [38–40]. We were, therefore, curious to see whether zebrafish
might be an advantageous model in which to study the effects of Alzheimer´s disease-like con-
ditions on MAM formation. Here, we determine the effects of inhibition of psen1 and psen2
activity, DAPT and sodium azide treatment on M-ER appositions in midline spinal cord cells
in the trunk region of zebrafish embryos. The treatment with DAPT, a potent γ-secretase
inhibitor, is of high interest to determine whether γ-secretase activity plays a direct role in
affecting MAM formation apposition. Chemical agents like sodium azide are commonly used
to mimic hypoxic conditions [41]. Sodium azide inhibits cytochrome-c oxidase (complex IV)
of the mitochondrial electron transport chain thereby causing mitochondrial dysfunction [41].
A reduced activity of complex IV has been demonstrated several times in AD [42–44]. Mito-
chondrial dysfunction is associated with increased levels of reactive oxygen species (ROS) [45,
46] and there is increasing evidence suggesting the involvement of oxidative stress in AD [47–
50]. There is also a large body of evidence suggesting that hypoxia plays a role in AD pathogen-
esis via its effect on cerebrovasculature. Correct functioning of cerebrovasculature is crucial
for sufficient supply of oxygen and glucose to the brain. Reduced cerebral blood flow and
changes in cerebrovasculature have been observed in AD [51–53]. Hence, sodium azide is a
suitable compound to study the role of hypoxia in AD pathogenesis.
Methods
Ethics statement
All zebrafish work was performed under the auspices of The Animal Ethics Committee of The
University of Adelaide.
Animal husbandry
Wild-type zebrafish were maintained in a recirculated water system with a 14 hour light/10
hour dark cycle. Fertilized embryos were grown at 28˚C in aqueous support embryo medium
(E3)[54].
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Morpholino microinjection of zebrafish embryos
The morpholinos used in this work have been extensively valided in our previous research [55,
56]. Morpholinos were synthesized by Gene Tools LLC (Corvallis, OR, USA) and are listed in
Table 1. Fertilized zebrafish embryos were rinsed in E3 medium and injected at the one cell
stage. To ensure consistency of MO injections, zebrafish eggs were always injected with solu-
tions at 1 mM total concentration. (i.e. 0.5 mM MoPS1Tln + 0.5 mM MoPS2Tln, or 1.0 mM
MoCont on its own).
γ-Secretase inhibitor IX treatment
γ-Secretase Inhibitor IX (DAPT, N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-
butyl ester) in DMSO was purchased from Calbiochem (San Diego, CA, USA). This was added
to the aqueous support E3 medium of 4 hpf embryos until they developed to 48 hpf so that the
final concentration was 100 μM with 1% DMSO. We [57] and others [12] have previously
shown this concentration to be effective in inhibiting γ-secretase activity in zebrafish embryos.
Sodium azide treatment
Exposure of larvae to sodium azide (NaN3, Sigma-Aldrich CHEMIE GmbH, Steinheim, Ger-
many) was performed at 100μM that we have previously demonstrated is an effective concen-
tration for mimicry of hypoxia [58, 59]. NaN3 was added to the aqueous support medium of 36
hpf embryos until they developed to 48 hpf.
Transmission electron microscopy
24 and 48 hpf zebrafish larvae were fixed in 4% paraformaldehyde, 1.25% glutaraldehyde in
PBS with 4% sucrose, pH 7.2 overnight at 4˚C, and rinsed in washing buffer (PBS with 4%
sucrose). Embryos were post-fixed in 2% osmium tetroxide, followed by dehydration through
an ethanol series, and rinsed with propylene oxide followed by resin infiltration. Embedded
embryos were sectioned laterally past the embryonic yolk ball, at the beginning of the yolk
extension using an ultramicrotome to obtain several 85nm thick sections of the spinal cord.
The ultrathin sections were stained with uranyl acetate and lead citrate and imaged on an
Olympus-SIS Veleta CCD camera in a FEI Tecnai G2 Spirit TEM. Images were obtained from
3 to 6 cells at the midline area of the spinal cord; this was performed for 3 embryos of each
treatment. The mitochondria-ER apposition lengths were measured using Image J software
and statistically analysed using Fisher’s exact test [60].
Results
A previous study by Area-Gomez et al. [32] found that MEFs as well as fibroblasts from
patients with fAD and sAD show increased lengths of M-ER apposition compared to wild type
(WT) cells. They found more appositions in the 50-200nm (long) and>200nm (very long)
ranges compared to WT MEFs which show more appositions in a shorter length range
<50nm. Interestingly, they found essentially no effect on the degree of M-ER apposition in
Table 1. Morpholino sequences.
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HeLa cells after treatment with DAPT. Zebrafish have proven to be a highly manipulable
model for analysis of PRESENILIN gene function and might prove to be a useful tool for analy-
sis of the role of these genes in communication between the ER and mitochondria. Therefore,
we sought to determine the effect of inhibition of psen1 and psen2 activity on M-ER apposition
in the zebrafish animal model. Since our broader research focus is Alzheimer’s disease we
wished to analyse M-ER apposition in a neural cell type. However, unlike analysis of M-ER
apposition in cultured cells, the central nervous system of developing zebrafish embryos con-
tains many cell types with varying energy production and protein secretion characteristics that
might affect the extent of M-ER apposition within cells and confound the statistical analysis
required to reveal changes in M-ER apposition length caused by experimental treatments.
Additionally, it can be difficult to identify particular neural cell types by morphological criteria
in sections observed by transmission electron microscopy (TEM). Therefore we chose cells
near the midline of the developing spinal cord in the mid-trunk region of the embryo as rela-
tively easily easy to identify reproducibly (by their position) and most likely representing a
proliferative progenitor cell type that had not adopted a final differentiated state.
Analysis in embryos at 24 hpf
In an initial experiment we examined zebrafish embryos at 24 hpf in which we had simulta-
neously blocked translation of both the zebrafish Psen1 and Psen2 proteins by injection of
embryos at the 1-cell stage with MOs binding over the start codons of the psen1 and psen2
mRNAs (MoPS1Tln plus MoPS2Tln respectively–we have previously used these successfully
in numerous experiments [38–40]. We injected an inactive MO (MoCont) as a negative con-
trol. To standardise the neural cell type examined we sectioned transversely through the rosto-
caudal axis of embryos in that area of the trunk region of the embryo featuring the yolk
extension (Fig 1). This region has an anatomical structure that does not vary greatly along the
rostro-caudal axis. We then sought to identify cells in the spinal cord adjacent to the midline
(Fig 2). Three embryos from each treatment were analysed. M-ER apposition lengths were
then examined in three cells from each embryo and all the data were combined (Figs 3 and 4).
A total of 23 appositions in MoCont-injected embryos and 25 appositions in MoPS1Tln and
MoPS2Tln co-injected embryos were observed.
The individual M-ER apposition length measurements from our analyses at 24 hpf are
shown in S1 Data. All EM images used for our analyses are available in S1–S6 Files.
Fig 1. Zebrafish embryo. Several sections of 85 nm thickness were obtained from the area posterior to the
yolk ball, within the yolk extension as indicated by the vertical line.
https://doi.org/10.1371/journal.pone.0179859.g001
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We analysed our results in a manner similar to published work using cultured cells [32, 61].
First, the M-ER appositions were classed into three ranges of length; <50 nm, 50–200 nM, and
>200 nm (Fig 4A and Table 2A). We were surprised by the similarity in overall M-EF length
distribution between the control and treated embryos. We also examined the data when
divided among five classes of length range; <50 nm, 50–100 nM, 100–150 nM, 150–200 nM,
and>200 nm (Fig 4B and Table 2B). Analysis by Fisher’s exact tests [60] showed no significant
difference in apposition length distribution between control embryos and those lacking zebra-
fish Presenilin activity. Total apposition events analysed were 23 in embryos injected with
MoCont and 25 in embryos injected with both MoPS1Tln and MoPS2Tln. p = 1 for three clas-
ses and p = 0.844 for five classes.
The failure to observe changes in M-ER apposition length was unexpected, especially con-
sidering that mouse Psen2 activity was recently shown to affect mitochondrial to ER tethering
via inhibition of Mitofusin2 activity in MEFs [62]. However, we reasoned that, possibly, zebra-
fish embryos retained sufficient Presenilin protein activity from before MO injection to allow
normal MAM formation. Since we had not controlled for Presenilin activity loss in our experi-
ment we decided to modify the experiment with additional treatments and controls. MO-
injected embryos were allowed to develop for 48 hours by which time the pigmentation-loss
and hydrocephalus phenotypes of Presenilin loss are obvious (see Fig 2 in [55]). This allowed
selection of embryos for which we were confident that MO-injection had been effective. We
also expanded the treatments to include inhibition of γ-secretase activity with the compound
DAPT [12], and inhibition of mitochondrial respiration (mimicking hypoxia) using sodium
azide [58].
Fig 2. The midline of the spinal cord region. M-ER apposition lengths were measured in 3–6 cells at the
midline area of the spinal cord at each embryo (such as those indicated by white arrowheads). Three embryos
were examined for each treatment. The white, dashed line indicates the midline of the spinal cord.
https://doi.org/10.1371/journal.pone.0179859.g002
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Fig 3. Electron microscopy of zebrafish neural cells. Cells were treated with morpholinos binding the start
codon of psen1 and psen2 mRNA (MoPS1Tln and MoPS2Tln respectively). Arrowheads indicate the region of
apposition between mitochondria (M) and endoplasmic reticulum (E) i.e. MAM.
https://doi.org/10.1371/journal.pone.0179859.g003
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Analysis in embryos at 48 hpf
Five treatment classes were examined; Untreated, γ-secretase inhibition (with 100 μM DAPT
from 4 hpf), hypoxia mimicry (with 100 μM sodium azide from 36 hpf), Presenilin activity loss
(injected with MoPS1Tln plus MoPS2Tln) and MO-injection negative control (injected with
MoCont). Since exposure to hypoxia slows embryo development, the treatment group exposed
Fig 4. Quantification of 24 hpf zebrafish embryo M-ER apposition lengths. Percentage observed for
each length class for 3 classes A) and 5 classes B). Total apposition events analysed were 23 in MoCont and
25 in MoPS1Tln/MoPS2Tln-injected embryos.
https://doi.org/10.1371/journal.pone.0179859.g004
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to sodium azide was allowed to develop until these embryos reached a stage equivalent to that
of 48 hpf embryos under normoxia (at 28.5˚C–they reached this developmental stage after a
delay of 6–8 hours). The effectiveness of the above treatments was confirmed by observation
for developmental delay (under mimicry of hypoxia), the loss of melanotic cells (melano-
phores) in the trunk region (under γ-secretase inhibition), and for loss of melanophores and
the occurrence of hydrocephalus (caused by Psen1 and Psen2 protein loss). Only embryos
showing the appropriate phenotypes were selected for analysis.
Once again, three embryos were examined per treatment and transverse sections were
taken through from the yolk extension region of the trunk. In this study, up to 6 cells were
examined from each embryo to reduce the possible confounding effects of measuring M-ER
apposition lengths in cells that might have different differentiation states.
The individual M-ER apposition length measurements from our analyses at 48 hpf are
shown in S2 Data. All EM images used for our analyses are available in S7–S11 Files.
As previously, we examined the M-ER appositions lengths when grouped into three and
five classes of range length (Fig 5 and Table 3A and 3B). Fisher’s exact tests [60] revealed no
significant differences in the distribution of M-ER apposition lengths for the various treat-
ments compared to their controls. Total apposition events analysed in untreated embryos were
41. For 3 classes, p = 0.779 for MoPS1Tln/MoPS2Tln compared to MoCont, p = 1 for DAPT
compared to untreated and p = 0.63 for sodium azide compared to untreated. For 5 classes,
p = 0.74 for MoPS1Tln/MoPS2Tln compared to MoCont, p = 0.667 for DAPT compared to
untreated and p = 0.844 for sodium azide compared to untreated.
Discussion
The 2012 study by Area-Gomez et al. [32], observed an increase M-ER apposition length in
MEFs lacking both Psen1 and Psen2 activity. Also, mimicry of hypoxia might be expected to
increase M-ER apposition length as cells attempt to increase mitochondrial activity. However,
Area-Gomez et al. [32] did not observe an increase in M-ER apposition when γ-secretase ac-
tivity was inhibited using DAPT. If the neural cells we examined in zebrafish embryos had
shown similar responses to the MEFs examined by Area-Gomez and colleagues we might have
expected to see increased M-ER apposition in the embryos injected with MOs blocking Psen1
and Psen2 translation and, possibly, in the sodium azide-treated embryos but not in the
DAPT-treated embryos. Unexpectedly we saw no significant differences in any treatment
group.
During the development of the zebrafish spinal cord, cells divide near the apical “surface”
(the midline) and terminally differentiating neurons migrate outwards (e.g. see [63]). Thus,
Table 2. A) Percentage observed per length class from 24hpf, 3 classes. B) Percentage observed per length class from 24 hpf embryos, 5 classes.
A
Treatment Length of region of apposition, mitochondrial perimeter (nm)
<50nm 50-200nm >200nm
MoCont injected (n = 22) 31.8%(7) 63.6%(14) 4.5%(1)
MoPS1Tln/MoPS2Tln injected (n = 25) 28%(7) 68%(17) 4%(1)
B
Treatment Length of region of apposition, mitochondrial perimeter (nm)
<50nm 50-100nm 100-150nm 150-200nm >200nm
MoCont injected (n = 23) 31.8%(7) 31.8%(7) 18.2%(4) 13.6%(3) 4.5%(1)
MoPS1Tln/MoPS2Tln injected (n = 25) 28%(7) 44%(11) 8%(2) 16%(4) 4%(1)
https://doi.org/10.1371/journal.pone.0179859.t002
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Fig 5. Quantification of 48 hpf zebrafish embryo M-ER apposition lengths. Percentage observed for each length class for 3 classes A-C) and 5 classes
D-F). Total apposition events analysed were 33 in MoCont, 42 in MoPS1Tln/MoPS2Tln, 56 in sodium azide and 65 in DAPT -injected embryos.
https://doi.org/10.1371/journal.pone.0179859.g005
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cells near the midline are likely to be proliferative and not to have taken on a particular dif-
ferentiation state. A subjective observation made during collection of the M-ER apposition
data reported in this paper is that these cells typically had large nuclei relative to the cytosolic
volume. While M-ER appositions occur mainly in perinuclear areas these were not very nu-
merous in the cell type we observed. This limited the statistical power of our analysis. Un-
fortunately, the methods available for quantitative assessment of M-ER apposition/MAM
formation are limited. While sectioning and analysis using EM allowed us, apparently, to
focus on one cell type, (and this would be essential for a quantitative, in vivo analysis) this
method is very labour intensive and expensive and limits the scale of research studies that can
be performed.
In mammalian cells, the majority of apposition lengths observed in wild type cells were
punctate (< 50 nm) [32] while in our study, the majority of apposition lengths were in the 50–
200 nm range. The cell type examined may also be a cause of this difference. Area-Gomez et al.
[32] used fibroblast cells from mice and AD patients while we examined putative neuronal
progenitor cells that probably have quite different energy and substrate requirements relative
to fibroblasts (see below). These differences may affect the interaction between mitochondria
and the ER.
Cells can control the activity of mitochondria via release of Ca2+ ions from the ER [64].
Mitochondria are attracted to the Ca2+ ion source to form M-ER appositions [65] and they use
the Ca2+ to support the activity of a number of enzyme systems (reviewed by [66]). However,
gene expression evidence supports a relatively hypoxic nature of embryogenesis in zebrafish
[58, 67] and proliferative/stem cells can be heavily reliant on glycolysis (reviewed by [68, 69]).
Our research focusses on neurodegeneration, and since brain is enriched in MAM we focussed
in this study on a neural cell type that we could, with reasonable confidence, identify reproduc-
ibly due to its position. However, it may be that this proliferative cell type, if already relatively
reliant on anaerobic glycolysis, is insensitive to treatments that would cause significant differ-
ences in M-ER apposition in terminally differentiated cells largely dependent on oxidative
phosphorylation such as neurons. It is possible that the genetic malleability of the zebrafish
embryo can yet be exploited to investigate the control of M-ER apposition/MAM formation by
Table 3. A) Percentage observed per length class from 48 hpf embryos, 3 classes. B) Percentage observed per length class from 48 hpf embryos, 5
classes.
A
Treatment Length of region of apposition, mitochondrial perimeter (nm)
<50nm 50-200nm >200nm
MoCont injected (n = 33) 39.4%(13) 54.5%(18) 6.1%(2)
MoPS1Tln/MoPS2Tln injected (n = 39) 38.4%(15) 59%(23) 2.6%(1)
Untreated (n = 41) 43.9%(18) 51.2%(21) 4.9%(2)
DAPT (n = 65) 43.1%(28) 52.3%(34) 4.6%(3)
Sodium azide (n = 56) 33.9%(19) 58.9%(33) 7.1%(4)
B
Treatment Length of region of apposition, mitochondrial perimeter (nm)
<50nm 50-100nm 100-150nm 150-200nm >200nm
MoCont injected (n = 33) 39.4%(13) 24.2%(8) 27.3%(9) 3.0%(1) 6.1%(2)
MoPS1Tln/MoPS2Tln injected (n = 42) 35.7%(15) 33.3%(14) 21.4%(9) 7.1%(3) 2.4%(1)
Untreated (n = 41) 43.9%(18) 34.1%(14) 7.3%(3) 9.8%(4) 4.9%(2)
DAPT (n = 65) 43.1%(28) 32.3%(21) 15.4%(10) 4.6%(3) 4.6%(3)
Sodium azide (n = 56) 33.9%(19) 33.9%(19) 12.5%(7) 12.5%(7) 7.1%(4)
https://doi.org/10.1371/journal.pone.0179859.t003
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observing a reproducibly identifiable non-neural, differentiated cell type with a high secretory
load (since MAM is responsible for oxidative protein folding). Cells of the zebrafish embryo’s
hatching gland are an obvious candidate but have no mammalian equivalent and so have less
than optimal translational relevance.
Conclusions
We observed no significant difference in the distribution of M-ER apposition lengths in api-
cally located cells of the developing spinal cord in the trunk of zebrafish embryos between indi-
viduals injected with negative control morpholinos and those injected with morpholinos for
simultaneous blockage of Psen1 and Psen2 translation at 24 and 48 hours post fertilization.
Furthermore, we observed no significant difference in the distribution of M-ER apposition
lengths in such cells between embryos treated with DAPT or sodium azide and in untreated
embryos at 48 hours post fertilization. The inconsistency between our observations and those
performed in mammalian systems may be due to differences in cell type, developmental stage
and/or differences in vertebrate species. Future studies should examine other zebrafish cell
types and ages.
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